In the Realm of Hungry Ghosts: Close Encounters with Addiction

By Gabor Maté

10 min read

Why does it matter? Because the assumptions you carry about addiction — and about yourself — are almost certainly wrong.

You have a theory about the woman wheeling herself down East Hastings Street: bad choices, weak will, a fork in the road she took wrong. The woman has infected wounds where her knee used to bear weight. She has HIV. She is thirty-one years old. She is also, as her physician will come to understand, running the same internal machinery as he is — the same hunger, the same circuit, the same chase — though the world would never group them together. Gabor Maté spent years in Vancouver's most desperate postal code before he accepted what the neuroscience was telling him: that "addict" and "the rest of us" is a line drawn in sand by people who have not looked closely enough at themselves. This book makes you look.

Every Resident of Vancouver's Drug Colony Was Once a Child Who Needed Something

Nick is weeping in a Vancouver clinic, trying to explain to his doctor why he injects heroin and crystal meth. He uses, he says, specifically to avoid what surfaces when he isn't using: a quality of suffering carried since childhood, when his father spent years telling him and his twin they were worthless. His twin committed suicide as a teenager. Nick has been chemically managing what remained ever since.

Six words of biography doing the work of a whole theory.

Gabor Maté spent eight years as the staff physician for the Portland Hotel Society, the nonprofit managing supported housing for the neighborhood's most marginalized residents, in Vancouver's Downtown Eastside, Canada's drug capital, a few blocks near Main and Hastings. The hotels he served housed people the rest of the system had stopped expecting to recover: over a third carried HIV, more than half had a psychiatric diagnosis, and Indigenous people were five times more concentrated here than in the general population. Death was constant and often quiet. A woman Maté had seen in his office the previous week — cheerful, filling out welfare forms, in good spirits — was found dead in her room the following morning. She died sometime in the night, alone.

What the book strips away, patient by patient, is the story that addiction is a failure of will or a bad decision. Nick didn't choose the father who told him he was nothing. He didn't choose to watch his twin die. He chose the needle the same way anyone chooses anything that makes an unbearable thing bearable. That's not weakness. That's an answer — to a question most of us are lucky enough never to have been asked.

Addiction Is the Best Answer They Could Find to a Problem You Haven't Had to Face

The drug is not the problem. It is the solution — the only one the person found that actually worked — to a problem you may never have had to face.

Allan was in his forties when Maté reviewed his chart with him: heart failure, endocarditis, HIV, hepatitis C, a father and brother both dead of cardiac disease. His own legs were swollen because his heart couldn't pump properly. He looked at Maté helplessly and asked what he should do. So Maté laid it out: every risk factor, the full picture. Allan's response was to ask Maté to call him a "fucking retard," because, he said, that was the only way he learned. Maté obliged. Then he caught himself: the trouble was that Allan wasn't ignorant; he was addicted, and those were different problems entirely. Allan died four months later, from adulterated methadone stolen in a pharmacy break-in that killed at least eight people.

The scene matters because of what it eliminates. Allan already knew. He had just recited his own death sentence to his doctor. That knowledge changed nothing. The question he needed answered wasn't "what are the consequences?" It was "what is this drug doing for me that nothing else does?"

One patient told Maté that death held no fear for him. It was waking up, sober, in his own body each morning that he could not face. That's not a failure to weigh risk. That's someone for whom ordinary waking consciousness is itself an emergency. The drug doesn't produce euphoria so much as it quiets something that runs continuous and terrible underneath.

Across patient interviews, Maté distills what the drugs are actually solving. For some it is emotional anaesthesia — the ability to stop feeling what chronic trauma left behind. The harder version to treat is the vacancy: an emptiness so persistent they've come to mistake it for their personality. Stephen Reid received his first morphine hit at eleven, from a physician who then sexually exploited him for months. He described it as "a place of safety that came before pain and danger, before the enormity of being born." Not euphoria — the simple feeling of being okay, which his nervous system, shaped by a raging alcoholic father, had never reliably produced on its own. Once you've felt that, stopping means going back to being no one. The pharmacology varies by person and substance. The underlying logic is consistent: something broke down in emotional regulation long before any drug appeared, and the drug restores just enough function to make the day survivable.

That is not an excuse. It is a diagnosis.

'The First Time I Did Heroin, It Felt Like a Warm Soft Hug' — That Is Neurological Precision, Not Poetry

The pup doesn't cry. Separated from its mother, placed alone in a strange cage, an infant rat with normally functioning opioid receptors will call out, ultrasonic signals that say bring her back, bring her back. But researchers who genetically removed those receptors found something precise: no crying, no urgency, no drive to close the distance. Cold still alarmed the pups. The scent of a male intruder still alarmed them. Their fear system worked. But their attachment system, the chemistry of longing for the creature their lives depended on, was simply absent.

This is the circuit heroin enters.

Endorphins, the brain's own opioids, govern the emotional bonding between mother and infant. When a mother interacts lovingly with her baby, endorphin levels surge in both of them. This is not sentiment; it's the mechanism by which mammalian infants survive. Nature had to make parenting rewarding enough to sustain the tremendous thanklessness of it, so she made the attentive presence of a nurturing adult produce an endorphin surge in the child, a flood of calm and connection. When a child senses emotional separation, the anterior cingulate cortex fires. The crying is a distress signal evolved to trigger the parent's response, which restores the chemistry in both. That loop — need, signal, attentive response, endorphin release — is how the system was supposed to develop.

When that loop never reliably closed, the system learns to expect nothing. It runs on a starved budget.

And then, one day, a chemical arrives that floods those same receptors directly.

A woman Maté treated in Vancouver's Downtown Eastside, twenty-seven years old, HIV positive, working in the sex trade, described heroin's first effect in six words: like a warm soft hug. She died soon after. But what she felt wasn't manufactured euphoria. It was the same circuitry that should have answered her distress calls years earlier, finally responding. The drug didn't introduce something foreign into her brain. It occupied receptors that had been waiting, undertriggered, possibly her whole life.

The warm soft hug was real. The tragedy is that it came thirty years late, and through a needle.

The Addiction Begins Long Before the First Drug

The brain that will one day reach for a drug is being built — or not being built — in the first years of life, before any drug exists. The systems that make a person vulnerable (dopamine circuits governing motivation, opioid pathways managing attachment, prefrontal regions regulating impulse) are not fixed at birth. They wire themselves in those years, shaped by the emotional environment. That wiring is mostly done before any kid is old enough to be handed a substance.

The mechanism has a name: neural Darwinism. Of all mammals, humans arrive most neurologically incomplete. A horse runs on its first day; a human can barely focus. The pelvis narrowed for upright walking, so birth had to happen earlier. Ninety percent of brain development happens outside the womb, shaped by what the world provides.

In those early years, the infant brain produces far more connections than it will ever use, billions in excess. Which ones survive depends almost entirely on what fires repeatedly. Canadian neuroscientist Donald Hebb identified the mechanism: neurons that activate together form stronger links; those that never fire in sync get trimmed away. Apply that to a child whose earliest environment is cold or threatening, and you can see what gets built. The circuits encoding distress fire constantly, strengthening. The circuits that should develop alongside consistent warmth (dopamine reward pathways, opioid comfort loops, the prefrontal brake on impulsive behavior) are left thin and underconnected. Not broken by any single event. Simply never built.

This is what the epidemiology measures. Researchers studying over seventeen thousand largely college-educated Americans tracked ten categories of childhood adversity — abuse, family violence, parental mental illness, loss. For each adverse experience, substance dependence risk doubled to quadrupled. Five or more experiences produced a seven-to-tenfold increase. The researchers described their findings as results "of an order of magnitude rarely seen in epidemiology and public health." Nearly two-thirds of injection drug use traces back to abusive or traumatic childhood conditions.

Two-thirds. In a population that skewed educated and stable.

The statistics and neuroscience converge on the same thing the patient portraits already suggested: by the time most addicts first picked up a drug, the vulnerability was already there, thinned circuits and a stress response permanently set to hair-trigger. The drug arrived later. The damage came first.

The Physician Treating Addicts and the Addict He's Treating Are Running the Same Code

Sometime in the middle of a woman's labor, her doctor disappeared.

Not the kind of disappearance that gets reported. Not a cardiac emergency down the hall, not a collapsed patient. Maté simply drove across Vancouver to Sikora's classical music store, because he had to have a recording he'd been thinking about. He got there. He browsed. He picked up more than one disc. By the time he returned to the hospital, the baby had been born without him. The mother was understanding; she'd heard he was a busy man.

He is the doctor. He is also the addict. These are the same person.

Maté spent close to eight thousand dollars on compact discs in a single week. He lied to his wife Rae about the purchases for months, stashing bags on the porch, deflecting questions, covering his trail with the practiced evasion of someone who understood, clinically, every mechanism he was deploying. He owned five complete recordings of Beethoven's piano sonatas, five of the string quartets, six of the nine symphonies. Many had never been played. Some he'd bought, sold, and bought again. He describes walking up to Sikora's door and pausing just before he enters: for that one moment, the world opens. Then he goes inside, the feeling evaporates, and the next search begins before he's out the door.

This is not about classical music. The object is interchangeable. What the needle does for someone in Vancouver's Downtown Eastside, the hunt for a tenor recording does for the physician treating them. In both cases: dopamine released in anticipation, a brief reprieve from the craving state, then the craving resumed, slightly worse than before.

The question that separates passion from addiction is simple: who is in charge? Passion generates energy and moves outward toward other people. Addiction turns inward, consuming what it touches and then the people nearby. Maté was simultaneously counseling a patient named Sean about being honest with his family while preparing to go home and lie to his wife. He noticed this without blinking. That flat, unsparing recognition — that he and Sean were running the same code — is what the whole book is finally about.

The Part of the Brain That Says 'No' Is the First Thing Addiction Damages

The question follows naturally from the last mirror: if we're all running the same craving machinery, why can't they just stop the way a passionate collector can put down his credit card? The brain science lands somewhere more uncomfortable.

Don was waiting in Maté's office for his methadone prescription when he mentioned, almost as an aside, that he had urinated on a man's leg outside the pharmacy. The man had been bothering him. When Maté pressed him (was that appropriate?), Don considered it briefly. "No, pretty stupid," he said. "But it's like I'm a child not released."

He meant it as confession. Maté took it as neuroscience.

The brain region most responsible for saying no, the orbitofrontal cortex tucked just above the eye sockets, does two conflicting things in addiction. One sub-region fires automatically the moment an addict thinks about her drug: dopamine surges, craving intensifies. A neighboring sub-region is supposed to weigh consequences and override the impulse. In active craving, imaging studies show the first hyperactivated and the second simultaneously suppressed. The organ driving the addiction is the same organ that would stop it.

The margin for intervention is measurable and small. Electrical recordings show the brain generating an action signal nearly half a second before it reaches conscious awareness. The window in which the cortex can actually cancel the behavior — what researchers call "free won't" rather than free will — is less than a fifth of a second. When that gap has been narrowed by years of drug use, or was never properly built because early childhood was absent or chaotic, the window closes.

Don's phrase "child not released" was not colorful speech. The inhibitory circuitry that matures through stable early development simply never formed in him. The drugs then damaged what little existed. The choice to stop requires a brain region that addiction has already compromised — and that, in most cases, the person's history had impaired long before any drug arrived.

The Science Doesn't Ask for Tolerance — It Demands Compassion

Clarissa is thirty-one, pregnant, high on cocaine, and explaining to Maté why she hates herself. Her mother died of an overdose when Clarissa was five. Her father abused her from infancy. Three children already removed by child protection. She cycles from self-accusation to demands to collapsing, face in her palms: "I'm scared. I'm so very scared."

Maté listens. Then, as she's leaving, he offers a question rather than a verdict: what if you replaced the self-hatred with curiosity — genuine curiosity about why someone in your situation would reach for drugs? She considers it. She says she'd give a child with her history tough love. He says: forget the tough. Just love.

That's not therapy-speak. It's a precise diagnostic move. The self-loathing Clarissa carries doesn't compete with her addiction — it feeds it. Shame is a stress state, and stress is the most reliable trigger for both continued use and relapse. The spiral runs: use, shame, shame deepens the pain, use again. Breaking it requires interrupting the shame. That's what compassion does. Not acceptance of the behavior. Accurate seeing of the cause.

That same logic, applied at scale, works. Switzerland ran a heroin maintenance trial targeting its most refractory, repeatedly treatment-failed addicts (the thousand people everyone had given up on). The results: overall criminal offences dropped by sixty-eight percent, permanent employment more than doubled, not a single fatal overdose from the prescribed substances. Vancouver's supervised injection site saw nearly five hundred overdoses in eighteen months, and zero deaths. More than twenty peer-reviewed studies confirmed the cascade: less public injection, less needle sharing, more people entering detox. The evidence isn't ambiguous.

Conrad Black, with board seats, inherited wealth, and a media empire, was running the same hunger-and-acquisition loop as the person on East Hastings, just with a stock portfolio instead of a needle.

The obstacle isn't evidence; it's ideology: the belief that suffering deters, that making things harder teaches people to choose better. That belief assumes addiction is a choice that consequences can correct, and it cannot survive what we now know about how choice itself is built. Once you understand that the person reaching for the needle is managing an emotional emergency with the only tool they found that worked, one question remains: what are you going to offer instead?

The Question the Book Leaves You Carrying

The question you came in with — why won't they just stop — turns out to be the wrong question. Not cruel, not stupid. Wrong. A damaged orbitofrontal cortex cannot heal itself through determination. A brain that never built self-regulation in childhood cannot build it in a jail cell. The science doesn't ask you to excuse anyone. It asks you to look at what was already present before the first drug: the precise shape of a life that made oblivion feel safer than consciousness. What that leaves you with is harder than blame. Blame ends the inquiry. Accurate seeing extends it. Not into the addict's compulsions — into the inbox you check at 2am, the approval you can't stop needing, the project you can't put down even when it's finished. Into what we owe one another, and what help should actually mean. Compassion isn't softness here. It's the only position the evidence supports.